eribulin
Facts
14 properties- Instance of
- type of chemical entity
- Has use
- medication
- Active ingredient in
- Halaven
- Canonical SMILES
- CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O
- Chemical formula
- C₄₀H₅₉NO₁₁
- Isomeric SMILES
- C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*
- Mass
- 729.409 Da
- Medical condition treated
- breast cancer (2010–present)
- Physically interacts with
- Tubulin beta class I
- Pregnancy category
- US pregnancy category D
- Significant drug interaction
- anagrelide
- Stylized name
- eriBULin
- OpenAlex ID
- C2776387010
- ATC code
- L01XX41
- CAS Registry Number
- 253128-41-5
- ChEBI ID
- 63587
- ChEMBL ID
- CHEMBL1683590
- ChemSpider ID
- 24721813
- DSSTOX compound identifier
- DTXCID701436148
- DSSTox substance ID
- DTXSID101009321
- DrugBank ID
- DB08871
- DrugCentral ID
- 4171
- EC number
- 803-583-7
- ECHA Substance Infocard ID
- 100.230.372
Show all 35 identifiers +23
- Freebase ID
- /m/03mj0sv
- Guide to Pharmacology Ligand ID
- 6813
- InChIKey
- UFNVPOGXISZXJD-JBQZKEIOSA-N
- KEGG ID
- D08914
- LiverTox ID
- Eribulin
- MeSH descriptor ID
- C490954
- MedlinePlus drug identifier
- a611007
- Microsoft Academic ID (discontinued)
- 2776387010
- NCI Dictionary of Cancer Terms entry
- e7389
- NDF-RT ID
- N0000182260
- PDB ligand ID
- 6K9
- PDB structure ID
- 5JH7
- Probes And Drugs ID
- PD052173
- PubChem CID
- 11354606
- Reaxys registry number
- 9893060
- RxNorm CUI
- 1045453
- SureChEMBL ID
- 15783821
- UK Parliament thesaurus ID
- 434394
- UNII
- LR24G6354G
- UniChem compound ID
- 1027290
- WikiProjectMed ID
- Eribulin
Has use 1
Medical condition treated 1
Significant drug interaction 1
← Drug or therapy used for treatment 1
← Significant drug interaction 1
0 sources
Summary
eribulin is a type of chemical entity[1]. eribulin is a type of 20-(3-Amino-2-hydroxypropyl)-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.1~3,32~.1~3,33~.1~6,9~.1~12,16~.0~18,22~.0~29,36~.0~31,35~]hentetracontan-24-one[2].
Key Facts
- Physically interacts with: Tubulin beta class I[3]
- Canonical SMILES: CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O[4]
- Chemical formula: C₄₀H₅₉NO₁₁[5]
- Has use: medication[6]
- Significant drug interaction: anagrelide[7]
- Isomeric SMILES: C[C@@H]1C[C@@H]2CC[C@H]3C(=C)CC@@HCC[C@]45C[C@@H]6C@H[C@H]7C@@HC@@H[C@@H]8C@@HCCC@@HCC(=O)C[C@H]9C@HOC@@HCC@@HOC@@HCC[C@]45C[C@@H]6C@H[C@H]7C@@HC@@H[C@@H]8C@@HCCC@@HCC(=O)C[C@H]9C@HO[C@@H]([C">[8]
- Mass: 729.409 dalton[9]
- Medical condition treated: breast cancer[10]
- Pregnancy category: US pregnancy category D[11]
- Active ingredient in: Halaven[12]
- LiverTox likelihood score: LiverTox toxicity likelihood category E*[13]
- Stylized name: eriBULin[14]